Navigation Links
Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA
Date:10/29/2009

ROCKVILLE, Md., Oct.29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that its abstract has been selected for poster presentation at the Infectious Diseases Society of America (IDSA) 47th Annual meeting being held in Philadelphia, Pennsylvania from October 29 - November 1, 2009.

Poster presentation: "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Healthy Adults", Penny Heaton, M.D., Maria Allende, M.D., Kathy Lenhard, R.N., Mike Massare, PhD., and Mark Wolff, PhD. Saturday October 31, 2009 12:30 pm to 2:00 pm., Pennsylvania Convention Center, Poster Hall A.

About the 47th Annual Meeting of the IDSA

This conference will showcase abstract presentations containing outstanding, noteworthy science; and expanded roster of challenging interactive sessions; symposia on management of difficult pathogens, such as MRSA, Clostridium difficle, and drug-resistant mycobacteria, gram-negative bacillia and fungi; and the promises and challenges of new vaccines. The Special Plenary Session and Named Lectures will highlight important advancements as well as challenges in the world of infectious diseases. Additional information is available at www.idsociety.org.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The Company has formed a joint venture with Cadila Pharmaceutica
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. Novavax Reports First Quarter 2008 Financial Results
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax to Join Russell 3000 Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... the most attractive in the emerging European region, mainly ... and increasing government investment in healthcare, according to a ... set to grow at twice the pace of the ... reaching an approximate market value of $43-60 billion by ... Cross provides total healthcare solutions that address the evolving ...
(Date:3/25/2015)... March 25, 2015 Optimal Research, LLC has ... Excellence (ViE) Award "Best Clinical Site or Trial Network". ... Optimal has been selected as a nominee in this ... a "Highly Recommended" distinction in 2014. The ViE awards ... efforts, accomplishments, and positive contributions of companies and individuals ...
(Date:3/25/2015)... IL (PRWEB) March 25, 2015 ... Symmetry® Top-Loading Balances and Analytical Balances to get ... expanded line of weighing balances from the trusted ... Toploading Balances increase your efficiency by providing ... variety of samples. Weighing modes include parts counting, ...
(Date:3/25/2015)... March 25, 2015 An increase of ... in all forms of food nutrients, regulatory changes and ... substantial rise in demand for natural astaxanthin over the ... to ramp up their capacities to satisfy the rising ... and synthetic source astaxanthin (used in nutraceuticals, aqua feed, ...
Breaking Biology Technology:Optimal Research Nominated 2015 Vaccine Industry Excellence (ViE) Award 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2
... 2011 For a successful bioscience company there are ... institutions and knowledgeable workforce to suppliers and market access, ... solutions to today,s modern scientific challenges. Yet, leveraging these ... associated with R&D are high. Complexity in the supply ...
... SANTA CLARA, Calif., June 16, 2011 NewCardio, ... provider, announced today that two of its recent ... their presentations at the 33rd Annual International Conference ... Society conference.   The two papers: ...
... DNDN ) today announced that management will present at the NASDAQ ... 9:30 a.m. GMT (4:30 a.m. ET). The presentation will ... www.dendreon.com .  If you are unable to listen to the live ... To access the replay, go to the Investor Relations section of ...
Cached Biology Technology:Ohio's Bioscience Industry Thrives With World-Class Industry Collaboration 2Ohio's Bioscience Industry Thrives With World-Class Industry Collaboration 3Ohio's Bioscience Industry Thrives With World-Class Industry Collaboration 4NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 3NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 4
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Middle East , ... forecasts are provided for the period 2013 through 2020. Also, ... data and analytics are derived from primary and secondary research. ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Personal Data Protection Company Launches New Product 2World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11
... Des Moines, IA A new study by researchers at ... that standing and lying behavior can predict heat stress in ... Branch / ASAS Midwestern Section Meeting, Dr. Jamison Allen explained ... and productive. Cows will pant, eat less and produce less ...
... , March 12, 2013  Spiral Genetics, a cloud-based ... its Series A financing, led by venture capital firm ... mission to create revolutionary tools that empower the bioinformatics ... tomorrow. The company intends to use the funds to ...
... the most vibrant insects, with colorations sometimes designed to ... of these defenses may be driven by enemies one-tenth ... years ago, researchers have believed large predators like birds ... the first behavioral study to directly test the defense ...
Cached Biology News:Heat-stressed cows spend more time standing 2Spiral Genetics Closes $3 Million in Funding Led by DFJ and Announces Partnership with Omicia 2Spiral Genetics Closes $3 Million in Funding Led by DFJ and Announces Partnership with Omicia 3UF study shows spiders, not birds, may drive evolution of some butterflies 2UF study shows spiders, not birds, may drive evolution of some butterflies 3
7G10 anti-Fasciclin III...
Rabbit polyclonal to Nck alpha ( Abpromise for all tested applications). entrezGeneID: 4690 SwissProtID: P16333...
Rabbit polyclonal to P5 ( Abpromise for all tested applications). entrezGeneID: 10954 SwissProtID: Q14554...
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
Biology Products: